Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Insulin-Dependent, 12 × Opdualag × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Recurrence 2 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Central Nervous System Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1

Interventions

Nivolumab 3 Ipilimumab 2 tremelimumab 1 relatlimab 1 Opdualag 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04326257 2026-01-08

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

University of Pittsburgh

Phase 2 Completed

20 enrolled 13 charts

Diabetes Mellitus, Insulin-Dependent, 12, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡